<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04292171</url>
  </required_header>
  <id_info>
    <org_study_id>734275-7</org_study_id>
    <nct_id>NCT04292171</nct_id>
  </id_info>
  <brief_title>Gabapentin for Perioperative Pain Relief in Surgical Abortion</brief_title>
  <official_title>Gabapentin for Perioperative Pain Relief in Surgical Abortion: a Double-blind Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nevada, Las Vegas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nevada, Las Vegas</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gabapentin preoperative use for evaluation of benefit to reduce pain during and after&#xD;
      surgical office-based abortion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A double-blind placebo controlled trial of gabapentin in the setting of an ambulatory&#xD;
      surgical abortion center where patients receive either the routine intravenous sedation,&#xD;
      local cervical anesthesia plus 600mg of gabapentin one hour prior to surgery vs. the same&#xD;
      regimen plus placebo one hour prior to surgery. Our primary outcome measure will be&#xD;
      post-operative validated pain scores using a 11-point visual analog scale (VAS). Secondary&#xD;
      measures will include nausea and vomiting during, after and 24 hours after the procedure. A&#xD;
      second and third pain assessment using VAS will be made at 30 minutes and at 24 hours&#xD;
      postoperatively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Actual">March 30, 2018</completion_date>
  <primary_completion_date type="Actual">March 30, 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>double-blind placebo-controlled randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>pharmacy prepared sequentially numbered opaque bottles with identical capsules containing either placebo (vit c) or Gabapentin 600mg, block randomized</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Score</measure>
    <time_frame>5 minutes postoperative</time_frame>
    <description>100mm Visual analog scale (VAS) for level of pain, 1-100, 1=no pain, 100= extreme pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Score 24</measure>
    <time_frame>24 hours postop</time_frame>
    <description>Pain at 24 hours postoperative on 100mm VAS, 1=no pain, 100=extreme pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>Nausea at 24 hours using 100mm VAS, 1=none, 100=extreme</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vomiting</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>Vomiting at 24 hrs, 100mm VAS, 1=none, 100=extreme</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score at 30 Minutes Postoperative</measure>
    <time_frame>30 minutes postoperative</time_frame>
    <description>100mm Visual analog scale for level of pain, 1-100, 1=no pain, 100= extreme pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">219</enrollment>
  <condition>Pain Control</condition>
  <arm_group>
    <arm_group_label>Gabapentin Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gabapentin 600 mg given 1-2 hours prior to surgical abortion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (vit C) given 1-2 hours prior to surgical abortion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <description>Preoperative treatment with Gabapentin</description>
    <arm_group_label>Gabapentin Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>Preoperative treatment with Placebo</description>
    <arm_group_label>Placebo Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women seeking surgical abortion between 5 and 23 6/7 weeks of ultrasound age.&#xD;
&#xD;
          -  English or Spanish speaking&#xD;
&#xD;
          -  eligible for office-based surgical pregnancy termination&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  present use of gabapentin or pregabalin,&#xD;
&#xD;
          -  renal disease&#xD;
&#xD;
          -  sensitivity or allergy to gabapentin&#xD;
&#xD;
          -  Missed abortion&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vani Dandolu, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Nevada School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Birth Control Care Center</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>February 5, 2020</study_first_submitted>
  <study_first_submitted_qc>February 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2020</study_first_posted>
  <results_first_submitted>April 10, 2020</results_first_submitted>
  <results_first_submitted_qc>November 6, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 2, 2020</results_first_posted>
  <last_update_submitted>November 6, 2020</last_update_submitted>
  <last_update_submitted_qc>November 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nevada, Las Vegas</investigator_affiliation>
    <investigator_full_name>Adam Levy</investigator_full_name>
    <investigator_title>Associate Professor, OB/GYN</investigator_title>
  </responsible_party>
  <keyword>Gabapentin Abortion</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gabapentin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All of the participant data de-identified that was collected during the study.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Following publication and terminating 5 years following</ipd_time_frame>
    <ipd_access_criteria>Investigators must submit a Material Transfer Agreement for data transfer between UNLV School of Medicine and investigators institution. Investigators who demonstrate a legitimate proposal on the purpose for the data set, their intended analysis and schedule for anticipated publication will be considered. Investigators should submit their publications within 18 months of receiving the data set.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 1, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/71/NCT04292171/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Gabapentin Arm</title>
          <description>Gabapentin 600 mg given 1-2 hours prior to surgical abortion&#xD;
Gabapentin: Preoperative treatment with Gabapentin</description>
        </group>
        <group group_id="P2">
          <title>Placebo Arm</title>
          <description>Placebo (vit C) given 1-2 hours prior to surgical abortion&#xD;
Placebos: Preoperative treatment with Placebo</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="109"/>
                <participants group_id="P2" count="110"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="107"/>
                <participants group_id="P2" count="109"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Pharmacy error</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Delivered prior to procedure</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Gabapentin Arm</title>
          <description>Gabapentin 600 mg given 1-2 hours prior to surgical abortion&#xD;
Gabapentin: Preoperative treatment with Gabapentin</description>
        </group>
        <group group_id="B2">
          <title>Placebo Arm</title>
          <description>Placebo (vit C) given 1-2 hours prior to surgical abortion&#xD;
Placebos: Preoperative treatment with Placebo</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="107"/>
            <count group_id="B2" value="109"/>
            <count group_id="B3" value="216"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.7" spread="6.26"/>
                    <measurement group_id="B2" value="27.1" spread="6.03"/>
                    <measurement group_id="B3" value="27.4" spread="6.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="107"/>
                    <measurement group_id="B2" value="109"/>
                    <measurement group_id="B3" value="216"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Hispanic/Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White/Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black/ African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hawiian/Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>more than one</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="107"/>
                    <measurement group_id="B2" value="109"/>
                    <measurement group_id="B3" value="216"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pregnancy History</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Previous Pregnancy &quot;YES&quot;</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="88"/>
                    <measurement group_id="B3" value="170"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>History of Vaginal deliveries</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>History of cesarean delivery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>History of Abortions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>History of Miscarriages</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>History of Stillbirths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>history of ectopic pregnancy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>History of Surgical Abortion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Living Arrangements</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Alone</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>with Partner</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>with Children</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>with Friends</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>with Family</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Score</title>
        <description>100mm Visual analog scale (VAS) for level of pain, 1-100, 1=no pain, 100= extreme pain</description>
        <time_frame>5 minutes postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin Arm</title>
            <description>Gabapentin 600 mg given 1-2 hours prior to surgical abortion&#xD;
Gabapentin: Preoperative treatment with Gabapentin</description>
          </group>
          <group group_id="O2">
            <title>Placebo Arm</title>
            <description>Placebo (vit C) given 1-2 hours prior to surgical abortion&#xD;
Placebos: Preoperative treatment with Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score</title>
          <description>100mm Visual analog scale (VAS) for level of pain, 1-100, 1=no pain, 100= extreme pain</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="107"/>
                <count group_id="O2" value="109"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" lower_limit="0" upper_limit="60"/>
                    <measurement group_id="O2" value="17" lower_limit="2" upper_limit="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score 24</title>
        <description>Pain at 24 hours postoperative on 100mm VAS, 1=no pain, 100=extreme pain</description>
        <time_frame>24 hours postop</time_frame>
        <population>We lost to followup 40 in Gaba arm, 48 in the placebo arm at 24 hrs - these patients did not respond to our calls</population>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin Arm</title>
            <description>Gabapentin 600 mg given 1-2 hours prior to surgical abortion&#xD;
Gabapentin: Preoperative treatment with Gabapentin</description>
          </group>
          <group group_id="O2">
            <title>Placebo Arm</title>
            <description>Placebo (vit C) given 1-2 hours prior to surgical abortion&#xD;
Placebos: Preoperative treatment with Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score 24</title>
          <description>Pain at 24 hours postoperative on 100mm VAS, 1=no pain, 100=extreme pain</description>
          <population>We lost to followup 40 in Gaba arm, 48 in the placebo arm at 24 hrs - these patients did not respond to our calls</population>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="67"/>
                <count group_id="O2" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="20"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nausea</title>
        <description>Nausea at 24 hours using 100mm VAS, 1=none, 100=extreme</description>
        <time_frame>24 hours postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin Arm</title>
            <description>Gabapentin 600 mg given 1-2 hours prior to surgical abortion&#xD;
Gabapentin: Preoperative treatment with Gabapentin</description>
          </group>
          <group group_id="O2">
            <title>Placebo Arm</title>
            <description>Placebo (vit C) given 1-2 hours prior to surgical abortion&#xD;
Placebos: Preoperative treatment with Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Nausea</title>
          <description>Nausea at 24 hours using 100mm VAS, 1=none, 100=extreme</description>
          <units>VAS 100mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="68"/>
                <count group_id="O2" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.74" spread="10.923"/>
                    <measurement group_id="O2" value="1.74" spread="8.140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vomiting</title>
        <description>Vomiting at 24 hrs, 100mm VAS, 1=none, 100=extreme</description>
        <time_frame>24 hours postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin Arm</title>
            <description>Gabapentin 600 mg given 1-2 hours prior to surgical abortion&#xD;
Gabapentin: Preoperative treatment with Gabapentin</description>
          </group>
          <group group_id="O2">
            <title>Placebo Arm</title>
            <description>Placebo (vit C) given 1-2 hours prior to surgical abortion&#xD;
Placebos: Preoperative treatment with Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Vomiting</title>
          <description>Vomiting at 24 hrs, 100mm VAS, 1=none, 100=extreme</description>
          <units>VAS 100mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="68"/>
                <count group_id="O2" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" spread="6.063"/>
                    <measurement group_id="O2" value="0.74" spread="5.125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score at 30 Minutes Postoperative</title>
        <description>100mm Visual analog scale for level of pain, 1-100, 1=no pain, 100= extreme pain</description>
        <time_frame>30 minutes postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gabapentin Arm</title>
            <description>Gabapentin 600 mg given 1-2 hours prior to surgical abortion&#xD;
Gabapentin: Preoperative treatment with Gabapentin</description>
          </group>
          <group group_id="O2">
            <title>Placebo Arm</title>
            <description>Placebo (vit C) given 1-2 hours prior to surgical abortion&#xD;
Placebos: Preoperative treatment with Placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score at 30 Minutes Postoperative</title>
          <description>100mm Visual analog scale for level of pain, 1-100, 1=no pain, 100= extreme pain</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="107"/>
                <count group_id="O2" value="109"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="3" upper_limit="55"/>
                    <measurement group_id="O2" value="23" lower_limit="3" upper_limit="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 hours</time_frame>
      <desc>There were no reported adverse event in the study groups</desc>
      <group_list>
        <group group_id="E1">
          <title>Gabapentin Arm</title>
          <description>Gabapentin 600 mg given 1-2 hours prior to surgical abortion&#xD;
Gabapentin: Preoperative treatment with Gabapentin</description>
        </group>
        <group group_id="E2">
          <title>Placebo Arm</title>
          <description>Placebo (vit C) given 1-2 hours prior to surgical abortion&#xD;
Placebos: Preoperative treatment with Placebo</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="107"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="109"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="107"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="109"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="107"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="109"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Adam V. Levy MD</name_or_title>
      <organization>University of Nevada Las Vegas School of Medicine</organization>
      <phone>702-671-2300</phone>
      <email>adam.levy@unlv.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

